China Pharma Holdings
CPHI
8 hedge funds and large institutions have $884K invested in China Pharma Holdings in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
18% less capital invested
Capital invested by funds: $1.08M → $884K (-$195K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.82K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$7.52K |
| 2 |
Renaissance Technologies
New York
|
-$3.27K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$2.42K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $716K | – | – | – |
|
|
FWSM
2
First Wilshire Securities Management
Pasadena,
California
| $99K | – | – | – |
|
|
GA
3
Glenhill Advisors
New York
| $40K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $22K | -$3.27K | -27 | -11% |
|
|
5
Citadel Advisors
Miami,
Florida
| $2K | -$7.52K | -62 | -74% |
|
|
VKH
6
Virtu KCG Holdings
New York
| $2K | -$2.42K | -20 | -47% |
|
|
PCM
7
Parsons Capital Management
Providence,
Rhode Island
| $2K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | +$1.82K | +15 | New |
|
CPHI Hedge Fund Activity: Q3 2015 in Review
8 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2015, worth a combined $884K — down 18% from $1.08M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CPHI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $1.82K. The largest seller was Citadel Advisors, cutting an estimated $7.52K.
- 8 institutional investors held China Pharma Holdings (CPHI) as of Q3 2015, up from 7 in Q2 2015.
- Funds reported $884K of China Pharma Holdings stock for Q3 2015, down 18% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q3 2015 and 0 closed out, a net change of +1 holder.
- The largest China Pharma Holdings buyer in Q3 2015 was UBS Group, an estimated $1.82K added.
- The largest China Pharma Holdings seller in Q3 2015 was Citadel Advisors, an estimated $7.52K sold.
Based on aggregated 13F filings for Q3 2015.